After the launch of call 38 by BioWin, the NucleoGlio project emerged as a consortium between the coordinating company Belgian Volition SRL, in collaboration with QUALIblood SA, and the institutes UNamur-NARILIS and UCLouvain-IREC. Belgian Volition SRL, QUALIblood, UNamur and UCLouvain, working together as a consortium, have been granted EUR 2.2…
An extraordinary year for BioWin is coming to an end – a year full of significant milestones in our mission to accelerate innovation to meet tomorrow’s public health challenges and develop the knowledge, employment and competitiveness of all players in the health sector ecosystem. Review the best stories of 2023….
HealthTech Investor Summit connects European entrepreneurs and investors for the first time Bruges, Belgium, 16 November 2023 – The HealthTech Investor Summit in Bruges, Belgium, on 4-6 December is the first event to unite the European healthtech sector. This unique summit will bring together the largest group of healthtech investors…
Following the call 37 launched by BioWin, the Gloria project is the result of a consortium between the coordinating company Eonix, in partnership with two other companies, Comunicare Solutions and Kedroz, and the universities UCLouvain and UMons. Eonix, Comunicare Solutions, Kedroz, UCLouvain and UMons, working together as a consortium, have…
Business Village Ecolys
Avenue d’Ecolys 2
5020 Namur (Belgium)
Email : contact@biowin.org
VAT BE 0882.768.591
Website by Monkeys not Donkeys
© 2024 BioWin.
